Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?

E M W van de Garde; L R van Bedaf; D P Hurkmans; M M van den Heuvel

doi:10.1016/j.annonc.2020.09.007

Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?

E M W van de Garde
, L R van Bedaf
, D P Hurkmans
, M M van den Heuvel

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1779-1780
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	31
Issue number	12
DOIs	https://doi.org/10.1016/j.annonc.2020.09.007
Publication status	Published - Dec 2020
Externally published	Yes

Keywords

Anti-Bacterial Agents/therapeutic use
Antibodies, Monoclonal, Humanized
Carcinoma, Non-Small-Cell Lung
Humans
Immunotherapy
Lung Neoplasms/drug therapy
Proton Pump Inhibitors
Time

Access to Document

10.1016/j.annonc.2020.09.007

Cite this

van de Garde, E. M. W., van Bedaf, L. R., Hurkmans, D. P., & van den Heuvel, M. M. (2020). Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment? Annals of oncology : official journal of the European Society for Medical Oncology, 31(12), 1779-1780. https://doi.org/10.1016/j.annonc.2020.09.007

@article{af6af40dd024433a95fb04206a583a67,

title = "Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?",

keywords = "Anti-Bacterial Agents/therapeutic use, Antibodies, Monoclonal, Humanized, Carcinoma, Non-Small-Cell Lung, Humans, Immunotherapy, Lung Neoplasms/drug therapy, Proton Pump Inhibitors, Time",

author = "\{van de Garde\}, \{E M W\} and \{van Bedaf\}, \{L R\} and Hurkmans, \{D P\} and \{van den Heuvel\}, \{M M\}",

year = "2020",

month = dec,

doi = "10.1016/j.annonc.2020.09.007",

language = "English",

volume = "31",

pages = "1779--1780",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Elsevier Limited",

number = "12",

}

van de Garde, EMW, van Bedaf, LR, Hurkmans, DP & van den Heuvel, MM 2020, 'Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31, no. 12, pp. 1779-1780. https://doi.org/10.1016/j.annonc.2020.09.007

Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment? / van de Garde, E M W; van Bedaf, L R; Hurkmans, D P et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 31, No. 12, 12.2020, p. 1779-1780.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer

T2 - all the time or just at the start of treatment?

AU - van de Garde, E M W

AU - van Bedaf, L R

AU - Hurkmans, D P

AU - van den Heuvel, M M

PY - 2020/12

Y1 - 2020/12

KW - Anti-Bacterial Agents/therapeutic use

KW - Antibodies, Monoclonal, Humanized

KW - Carcinoma, Non-Small-Cell Lung

KW - Humans

KW - Immunotherapy

KW - Lung Neoplasms/drug therapy

KW - Proton Pump Inhibitors

KW - Time

U2 - 10.1016/j.annonc.2020.09.007

DO - 10.1016/j.annonc.2020.09.007

M3 - Article

C2 - 32976935

SN - 0923-7534

VL - 31

SP - 1779

EP - 1780

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

IS - 12

ER -